Medtech Big 100: These companies just missed the list

September 11, 2023 By Danielle Kirsh

Medtech Big 100: Just missed the list

No. 101: Glaukos

Revenue: $282,862,000
R&D expenditures: $123,271,000
Employees: 783
CEO: Thomas Burns
HQ: Aliso Viejo, California
www.glaukos.com

Glaukos ranked No. 95 in our 2022 Medtech Big 100 with $294 million in sales. Its drop from the 2023 ranking can be attributed to newcomers to the list and a decrease in its own sales. Glaukos develops ophthalmic medical devices for treating glaucoma, corneal disorders and retinal disease.

Medtech Big 100 analysis: Sales grow, jobs decrease, R&D spending climbs

Pages: 1 2 3 4 5 6

About The Author

Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.